Glass Health's AI platform works by clinicians entering basic patient details and symptoms, which then generates drafts of differential diagnosis and clinical health plans. The platform is designed to be doctor-facing, allowing clinicians to supervise and review the generated output before sharing it with the patient. The startup, which began as an online notebook for physicians, pivoted to an AI platform for diagnosis and clinical plans earlier this year.
Key takeaways:
- Glass Health, an AI-powered medical diagnosis platform, has raised $5 million in a seed round led by Initialized Capital. Other participants include Tom Lee, founder of One Medical, Epocrates, and Galileo Health; Connor Landgraf, founder and CEO of Eko Health; and Heather Hasson & Trina Spear, the co-founders of FIGS.
- The platform is designed to assist clinicians in diagnosis, clinical decisions, and drafting clinical plans by combining a large language model with evidence-based, peer-reviewed clinical guidelines. The aim is to increase diagnostic accuracy, improve patient outcomes, and eliminate clinician burnout.
- The AI platform works by clinicians entering basic details of the patient and their symptoms, which then generates drafts of differential diagnosis and clinical health plans. The platform is designed to be doctor-facing to ensure clinicians can supervise and review the generated output before applying it or sharing it with the patient.
- Glass Health originally began as an online notebook or a personal knowledge management system for physicians, but pivoted to an AI platform for diagnosis and clinical plans earlier this year.